|
Press Releases and Ad-hoc-Announcements 2006
December 29, 2006 |
| MOLOGEN AG out-licenses marketing rights for India
and receives further upfront payment
 more
|
December 27, 2006 |
| MOLOGEN AG receives upfront payment
more |
December 6, 2006 |
| MOLOGEN AG: Abu Dhabi health authorities do not
grant permission for patient treatment
more |
December 5, 2006 |
| MOLOGEN AG with new major shareholder
SALVATOR Asset Management crosses 5-percent threshold
more |
November 9, 2006 |
| MOLOGEN AG announces results of first nine months
2006 and out-licensing agreement for Asia
more |
October 25, 2006 |
| MOLOGEN AG receives Orphan Drug status for cell
based gene therapy for renal cance
more |
October 18, 2006
|
| MOLOGEN AG: Basic patent legally valid in Europ
more |
September 22, 2006
|
| MOLOGEN AG will receive patent for new technological
variant of MIDGE
more |
September 20, 2006
|
| MOLOGEN AG: Exclusivity for Cell-based Cancer
Treatment
more |
August 14, 2006
|
| MOLOGEN AG will receive patent for technological
variant of MIDGE
more |
August 10, 2006
|
| MOLOGEN closes second quarter of 2006:
Important contracts closed and good prospects although revenues still
low
Ad-hoc-Mitteilung more
Press Releases more
 Half-year Report 2006
download |
August 7, 2006
|
| MOLOGEN AG: Patent for DNA based vaccine against
important cat disease granted
more |
August 4, 2006
|
| MOLOGEN’s MIDGE vector wins "Frost
& Sullivan’s 2006 Technology Innovation of the Year Award"
Laudatio 2006
download |
June 8, 2006
|
| EMEA grants MOLOGEN AG medicine status for their
cell-based gene therapy
more |
June 8, 2006
|
| Annual Meeting of the MOLOGEN AG
more |
May 11, 2006
|
| MOLOGEN AG closes strategically successful first
quarter 2006
more |
April 27, 2006
|
| Major MOLOGEN shareholder increases investment
more
Further
information on Leishmaniasis |
April 19, 2006
|
| Major MOLOGEN shareholder increases investment
more |
March 30, 2006
|
| MOLOGEN supplies Emirates with Tumor Therapy
more |
March 29, 2006
|
| MOLOGEN presents overall result for the year:
Successful projects and sound financing provide solid basis for future
growth
more
Consolidated Financial
Report 2005 IFRS download |
March 6, 2006
|
| MOLOGEN's technological advancements enhance license
business potential. Strategic focus concentrated through termination of
Arab joint venture
more |
Febuary 20, 2006
|
|
MOLOGEN reviews extensive license agreement on
tumor therapy in India
more |
|
|
NEWSLETTER |
| To subscribe to our Newsletter please
 click here
|
|
|
PRESS
RELEASES 
